BIO-Europe 2026: KHAN, an early-stage investor based in Germany, works with academics to progress research projects, many of which turn into companies
Managing Partner Michael Hamacher tells us how it has connections to Max Planck and other European academic institutions. He also shares his thoughts on how companies should protect their ideas and IP.
Coverage brought to you by










.png)
